Influence of respiratory viruses on the evaluation of the 13-valent pneumococcal conjugate vaccine effectiveness in children under 5 years old: A time-series study for the 2001-2013 period | Zendy

A Hospital De Niños | Zendy; Ricardo Gutiérrez | Zendy; Ángela Gentile | Zendy; Del Valle Juárez | Zendy; Florencia Lución | Zendy; Sandra Romanin | Zendy; Norberto Giglio | Zendy; Julia Bakir | Zendy

Open Access

Influence of respiratory viruses on the evaluation of the 13-valent pneumococcal conjugate vaccine effectiveness in children under 5 years old: A time-series study for the 2001-2013 period

Author(s) -

A Hospital De Niños,

Ricardo Gutiérrez,

Ángela Gentile,

Del Valle Juárez,

Florencia Lución,

Sandra Romanin,

Norberto Giglio,

Julia Bakir

Publication year - 2015

Publication title -

archivos argentinos de pediatria

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.236

H-Index - 19

eISSN - 1668-3501

pISSN - 0325-0075

DOI - 10.5546/aap.2015.eng.310

Subject(s) - pneumococcal conjugate vaccine , medicine , respiratory system , pediatrics , pneumococcal infections , series (stratigraphy) , streptococcus pneumoniae , conjugate vaccine , covid-19 , virology , immunology , immunization , biology , microbiology and biotechnology , antigen , antibiotics , paleontology , disease , infectious disease (medical specialty)

S treptococcus pneumoniae is the main agent in bacterial consolidated pneumonias. In 2012, the 13-valent pneumococcal conjugate vaccine was introduced in the Argentine national immunization schedule for immunocompetent children as of two months old with a two-dose schedule plus a booster.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research